IIROC Trading Halt - BETR

The following issues have been halted by IIROC:

Company: BetterLife Pharma Inc.

CSE Symbol: BETR

All Issues: Yes

Reason: At the request of the Company Pending News

Halt Time (ET): 8:10 AM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada .

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions

View original content: https://www.newswire.ca/en/releases/archive/December2021/22/c0660.html

News Provided by Canada Newswire via QuoteMedia

cse:betrpharmaceutical investing
BETR:CNX
The Conversation (0)
Marvel Announces Final Shank3 Data: MB-204 Highly Effective at Reversing Autism Behaviours

Marvel Announces Final Shank3 Data: MB-204 Highly Effective at Reversing Autism Behaviours

Marvel Biosciences Corp. (TSXV: MRVL | OTCQB: MBCOF), and its wholly-owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), a drug discovery company developing novel therapeutics for autism spectrum disorder ("ASD") and related neurodevelopmental disorders, is... Keep Reading...
Marvel Biosciences

Marvel Biosciences

Keep Reading...
Medical professional's hand under a digital interface with a glowing cross and circuit design.

Eli Lilly Brings AI to Drug Delivery in METiS TechBio Deal

METiS TechBio (HKEX:7666) could collect up to US$1.1 billion in milestone payments from Eli Lilly and Company (NYSE:LLY) under a new research pact to design lipid nanoparticles that carry medicines to specific tissues in the body.Lipid nanoparticles, or LNPs, carry therapeutic payloads to target... Keep Reading...
BriaCell and BriaPro to Present Four Posters at SITC 2026 Annual Meeting

BriaCell and BriaPro to Present Four Posters at SITC 2026 Annual Meeting

briacell therapeutics corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) ("BriaCell" or the "Company"), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, and its majority-owned subsidiary, BriaPro Therapeutics Corp. ("BriaPro"), today announced that four... Keep Reading...
Two people wearing lab coats shake hands in business agreement.

Telix Acquires Germany's ITM in US$1.65 Billion Deal

Melbourne-based Telix Pharmaceuticals (ASX:TLX) has agreed to acquire Germany’s ITM Isotope Technologies to secure commercial-scale radioisotope manufacturing and expand into neuroendocrine tumor treatments.The deal brings ITM’s global radioisotope production and distribution network spanning... Keep Reading...
Data Safety Monitoring Board Recommends Continuing BriaCell's Phase 3 Metastatic Breast Cancer Study

Data Safety Monitoring Board Recommends Continuing BriaCell's Phase 3 Metastatic Breast Cancer Study

Independent DSMB reports no safety concerns to date and recommends continuing BriaCell's pivotal Phase 3 study of Bria-IMTâ„¢ plus an immune checkpoint inhibitorSeventh consecutive positive DSMB recommendation reinforces the favorable safety and tolerability of BriaCell's novel immunotherapy... Keep Reading...

Latest News

Interactive Chart

Latest Press Releases

iMetal Resources Files Gowganda West Technical Report

Multiple Chalice Style Gold Targets Identified

Triumph Gold Announces Director Appointment and Management Changes

55 North Gold Qualifies for Trading on the OTCQB Venture Market and Launches New Corporate Website

Related News

gold investing

iMetal Resources Files Gowganda West Technical Report

base metals investing

Multiple Chalice Style Gold Targets Identified

gold investing

Precious Metals Panelists: Is the Gold Market Too Complicated for Investors?

gold investing

Jeff Phillips: Biggest Commodities Bull Market? How I'm Positioning

precious metals investing

Triumph Gold Announces Director Appointment and Management Changes

precious metals investing

55 North Gold Qualifies for Trading on the OTCQB Venture Market and Launches New Corporate Website

precious metals investing

James Macintosh Appointed Chairman and CEO